The epigenetics of mantle cell lymphoma.

Current Treatment Options in Oncology
Margaret Yu, Elliot Epner

Abstract

There is no consensus treatment for newly diagnosed mantle cell lymphoma. The CHOP + rituximab and hyperCVAD + rituximab regimens are most commonly used. The former is limited by relatively lower rates of complete remission (CR) and frequent relapses. The latter is limited by toxicities, especially in older patients, and relapses that occur later than those usually seen with CHOP + rituximab. Thus, improved therapies are needed. The purine analog cladribine (2-cda) + rituximab has been studied as an alternative frontline regimen in MCL and is quite active with minimal toxicity. Cladribine has epigenetic activity in that it inhibits DNA methylation. Cladribine + rituximab should be further studied in newly diagnosed mantle cell lymphoma in combination with new agents such as inhibitors of histone deacetylation, the mTOR pathway, and the proteasome.

References

Apr 1, 1993·Current Opinion in Genetics & Development·P H Tate, A P Bird
Nov 14, 1998·Cell·D R Higgs
May 14, 1999·Current Opinion in Genetics & Development·H H Ng, A Bird
Sep 25, 1999·The Journal of Biological Chemistry·S KitazawaS Maeda
Aug 11, 2001·Science·T Jenuwein, C D Allis
Sep 6, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·E C Forsberg, E H Bresnick
Sep 24, 2002·Journal of Cellular Biochemistry·Theresa M Geiman, Keith D Robertson
Apr 30, 2003·Current Treatment Options in Oncology·Wolfgang Hiddemann, Martin Dreyling
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Mar 2, 2005·Seminars in Immunology·Chang-Zheng Chen, Harvey F Lodish
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jorge E RomagueraFernando F Cabanillas
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E Witzig
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Oct 28, 2005·The New England Journal of Medicine·George Adrian CalinCarlo M Croce

❮ Previous
Next ❯

Citations

Jun 1, 2011·Leukemia & Lymphoma·Stephen E SpurgeonElliot M Epner
Jul 17, 2009·Expert Opinion on Investigational Drugs·Stephen SpurgeonElliot M Epner
Jun 13, 2012·Best Practice & Research. Clinical Haematology·Zainul HasanaliElliot Epner
Mar 20, 2012·Cancer Letters·Sau Wai HungRajgopal Govindarajan
Jun 10, 2008·Current Opinion in Hematology·Mitchell R Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.